Abstract
To date, no effective treatment is available for advanced cancers, which remain a major cause of morbidity and mortality. Clearly, there is urgent need to unravel novel biomarkers for early detection. Proteomic approaches for the identification of novel biomarkers for cancer diagnosis and staging have traditionally relied on the identification of differentially expressed proteins between tumour cells and their normal counterparts based on the patterns of protein expression observed by two-dimensional gel electrophoresis (2DE-PAGE). Recent advances in mass spectrometry and bioinformatics and statistical algorithms necessary to interpret mass spectrometric data have revolutionized the approach to defining new tumour markers. Proteomics studies have generated numerous datasets of potential prognostic, diagnostic and therapeutic significance in human cancer. In this review we will discuss the available proteomic technologies their limitations and highlight the key areas of research required for understanding the aetiology of cancer and how they have been used to discover cancer biomarkers.
Keywords: Biomarkers, MALDI-TOF, mass spectrometry, 2DE gels, cancer
Current Cancer Therapy Reviews
Title: Application of Proteomics to the Discovery of Cancer Biomarkers
Volume: 4 Issue: 2
Author(s): Murrium Ahmad and Balwir Matharoo-Ball
Affiliation:
Keywords: Biomarkers, MALDI-TOF, mass spectrometry, 2DE gels, cancer
Abstract: To date, no effective treatment is available for advanced cancers, which remain a major cause of morbidity and mortality. Clearly, there is urgent need to unravel novel biomarkers for early detection. Proteomic approaches for the identification of novel biomarkers for cancer diagnosis and staging have traditionally relied on the identification of differentially expressed proteins between tumour cells and their normal counterparts based on the patterns of protein expression observed by two-dimensional gel electrophoresis (2DE-PAGE). Recent advances in mass spectrometry and bioinformatics and statistical algorithms necessary to interpret mass spectrometric data have revolutionized the approach to defining new tumour markers. Proteomics studies have generated numerous datasets of potential prognostic, diagnostic and therapeutic significance in human cancer. In this review we will discuss the available proteomic technologies their limitations and highlight the key areas of research required for understanding the aetiology of cancer and how they have been used to discover cancer biomarkers.
Export Options
About this article
Cite this article as:
Ahmad Murrium and Matharoo-Ball Balwir, Application of Proteomics to the Discovery of Cancer Biomarkers, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310089
DOI https://dx.doi.org/10.2174/157339408784310089 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prostate Cancer Imaging: A New Era in Diagnostic Approach
Recent Patents and Topics on Imaging (Discontinued) Role of Lipoxins and Resolvins as Anti-Inflammatory and Proresolving Mediators in Colon Cancer
Current Molecular Medicine Photodynamic Therapy in Melanoma - Where do we Stand?
Current Medicinal Chemistry The Effects of Newer Beta-Adrenoceptor Antagonists on Vascular Function in Cardiovascular Disease
Current Vascular Pharmacology Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Nongenomic Actions of Retinoids: Role of Nur77 and RXR in the Regulation of Apoptosis and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry An Overview of Targeting Legumain for Inhibiting Cancers
Current Pharmaceutical Design Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Current Diabetes Reviews The Promise of Antimicrobial Peptides for Treatment of Human Schistosomiasis
Current Drug Targets Potential Therapeutic Application of the Association of Vitamins C and K3 in Cancer Treatment
Current Medicinal Chemistry Application of Chiral α-Monofluorocarbonyl Compounds to Analytical and Medicinal Chemistry
Current Organic Chemistry Bacterial Zinc Proteases and their Inhibition
Current Enzyme Inhibition Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Azo Dye Degrading Enzyme Research
Current Protein & Peptide Science Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics
Current Medicinal Chemistry Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes
Endocrine, Metabolic & Immune Disorders - Drug Targets Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
Current Medicinal Chemistry Viral and Non-Viral Approaches for Transient Delivery of mRNA and Proteins
Current Gene Therapy The Accomplices of NF-κB Lead to Radioresistance
Current Protein & Peptide Science NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Current Pharmaceutical Design